Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Glode

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Prostate Cancer and Prostatic Diseases|December 24, 2002
Refractory disease, new horizons and patient-physician relationshipsL M Glode, D P Petrylak, L M Glode
Experimental Hematology|January 1, 1979
Dose limiting extramedullary toxicity of high dose chemotherapyL M Glode
Urology|January 1, 1986
The biology of gonadotropin-releasing hormone and its analogsL M Glode
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1976
Genetic control of B cell activation by bacterial lipopolysaccharide is mediated by multiple distinct genes or allelesL M Glode, D L Rosenstreich
The Journal of Urology|January 1, 1987
Long-term suppression of luteinizing hormone, follicle-stimulating hormone and testosterone by daily administration of leuprolideL M Glode, J A Smith
JAMA|July 26, 1985
LHRHL M Glode, J A Smith
Hematology/Oncology Clinics of North America|August 30, 2001
Internet oncology: increased benefit and risk for patients and oncologistsM J Mazzini, L M Glode
Oncology (Williston Park, N.Y.)|June 1, 1997
Current challenges of gene therapy for prostate cancerG S Harrison, L M Glode
The Journal of Urology|May 23, 1998
Flutamide induced lupusM B Reid, L M Glode
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1975
Difference in B cell mitogen responsiveness between closely related strains of miceD L Rosenstreich, L M Glode
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Prostate Cancer and Prostatic Diseases|December 24, 2002
Refractory disease, new horizons and patient-physician relationshipsL M Glode, D P Petrylak, L M Glode
Experimental Hematology|January 1, 1979
Dose limiting extramedullary toxicity of high dose chemotherapyL M Glode
Urology|January 1, 1986
The biology of gonadotropin-releasing hormone and its analogsL M Glode
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1976
Genetic control of B cell activation by bacterial lipopolysaccharide is mediated by multiple distinct genes or allelesL M Glode, D L Rosenstreich
The Journal of Urology|January 1, 1987
Long-term suppression of luteinizing hormone, follicle-stimulating hormone and testosterone by daily administration of leuprolideL M Glode, J A Smith
JAMA|July 26, 1985
LHRHL M Glode, J A Smith
Hematology/Oncology Clinics of North America|August 30, 2001
Internet oncology: increased benefit and risk for patients and oncologistsM J Mazzini, L M Glode
Oncology (Williston Park, N.Y.)|June 1, 1997
Current challenges of gene therapy for prostate cancerG S Harrison, L M Glode
The Journal of Urology|May 23, 1998
Flutamide induced lupusM B Reid, L M Glode
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1975
Difference in B cell mitogen responsiveness between closely related strains of miceD L Rosenstreich, L M Glode
Pageof 7